Home / Non‐Biological Complex Drugs
Non‐Biological Complex Drugs
News![]() Sandoz, the generics division of Novartis, announced on 13 February 2018 the approval of its 40 mg follow-on version of... |
Research![]() The advent of biological medicines has significantly transformed the landscapes of many disease spaces and improved the lives... |
Guidelines![]() Last update: 1 June 2018The regulatory body for approval of medicines in the US is the Food and Drug Administration (FDA). |
Polices & Legislation![]() As part of the Generic Drug User Fee Amendments (GDUFA II) reauthorization recently agreed with industry [1], the US Food and... |
Reports![]() Complex drug products and their generic (or follow-on) versions was the subject discussed at the New York Academy of Sciences... |
Generics News Research General
- Adherence improves long-term prognosis and medi...Generics/Research | Posted 19/02/2021
- Anti-competitive strategic patenting by pharmac...Generics/Research | Posted 12/02/2021
- Biocon and Lupin launch generic tacrolimus caps...Generics/News | Posted 05/02/2021
- New generics company to offer low-cost versions...Generics/General | Posted 29/01/2021
Biosimilars News Research General
- Canada approves infliximab biosimilar Remsima SCBiosimilars/News | Posted 19/02/2021
- Innovent starts phase II trial for ipilimumab c...Biosimilars/News | Posted 19/02/2021
- EMA recommends approval of adalimumab biosimila...Biosimilars/News | Posted 12/02/2021
- Canada approves insulin aspart biosimilar TrurapiBiosimilars/News | Posted 12/02/2021